Krieger et al. [21] reported that intermittent hypoxemia in OSA suppressed platelet responses to epinephrine and thrombin and decreased the level of the surface marker CD40L, thus signifying increased platelet activation, and it was also demonstrated that platelet activation in hypoxic mice can contribute to hypoxia-induced inflammation [22]. Here, CD40LG is linked to obstructive sleep apnea syndrome.